Risk-Specific Optimal Cancer Screening Schedules: An Application to Breast Cancer Early Detection

被引:6
作者
Ahern C.H. [1 ]
Cheng Y. [2 ]
Shen Y. [3 ]
机构
[1] Division of Biostatistics, Dan L. Duncan Cancer Center at Baylor College of Medicine, Houston, TX 77030, One Baylor Plaza
[2] Department of Mathematical Sciences, Indiana University South Bend, South Bend, IN 46634
[3] Department of Biostatistics, UT-M.D. Anderson Cancer Center, Houston, TX 77230, P.O. Box 301402
基金
美国国家卫生研究院;
关键词
Cancer screening; Non-stable disease model; Optimal exam times; Screening sensitivity; Sojourn time; Utility function;
D O I
10.1007/s12561-011-9032-7
中图分类号
学科分类号
摘要
The optimal schedules for breast cancer screening in terms of examination frequency and ages at examination are of practical interest. A decision-theoretic approach is explored to search for optimal cancer screening programs which should achieve maximum survival benefit while balancing the associated cost to the health care system. We propose a class of utility functions that account for costs associated with screening examinations and value of survival benefit under a non-stable disease model. We consider two different optimization criteria: optimize the number of screening examinations with equal screening intervals between exams but without a prefixed total cost; and optimize the ages at which screening should be given for a fixed total cost. We show that an optimal solution exists under each of the two frameworks. The proposed methods may consider women at different levels of risk for breast cancer so that the optimal screening strategies will be tailored according to a woman's risk of developing the disease. Results of a numerical study are presented and the proposed models are illustrated with various data inputs. We also use the data inputs from the Health Insurance Plan of New York (HIP) and Canadian National Breast Screening Study (CNBSS) to illustrate the proposed models and to compare the utility values between the optimal schedules and the actual schedules in the HIP and CNBSS trials. Here, the utility is defined as the difference in cure rates between cases found at screening examinations and cases found between screening examinations while accounting for the cost of examinations, under a given screening schedule. © 2011 International Chinese Statistical Association.
引用
收藏
页码:169 / 186
页数:17
相关论文
共 20 条
[1]
Detailed guide: breast cancer, Can breast cancer be found early?, (2006)
[2]
Breast cancer facts and figures 2009-2010, (2010)
[3]
Boer R., Plevritis S., Clarke L., Diversity of model approaches for breast cancer screening: a review of model assumptions by the Cancer Intervention and Surveillance Network (CISNET) Breast Cancer Groups, Stat Methods Med Res, 13, pp. 525-538, (2004)
[4]
Day N.E., Walter S.D., Simplified models of screening for chronic disease: estimation procedures from mass screening programmes, Biometrics, 40, pp. 1-14, (1984)
[5]
Knudsen A.B., McMahon P.M., Gazelle G.S., Use of modeling to evaluate the cost-effectiveness of cancer screening programs, J Clin Oncol, 25, pp. 203-208, (2007)
[6]
Lee S.J., Zelen M., Scheduling periodic examinations for the early detection of disease: applications to breast cancer, J Am Stat Assoc, 93, pp. 1271-1281, (1998)
[7]
Mandelblatt J.S., Cronin K.A., Bailey S., Berry D.A., Dekonig H.J., Draisma G., Huang H., Lee S.J., Munsell M., Plevritis S.K., Ravdin P., Schechter C.B., Sigal B., Stoto M.A., Stout N.K., van Ravesteyn N.T., Venier J., Zelen M., Feuer E.J., Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms, Ann Intern Med, 151, pp. 738-747, (2009)
[8]
Mandelblatt J.S., Schechter C.B., Yabroff K.R., Lawrence W., Dignam J., Muennig P., Chavez Y., Cullen J., Fahs M., Benefits and costs of interventions to improve breast cancer outcomes in African American women, J Clin Oncol, 22, pp. 2554-2566, (2004)
[9]
Breast cancer: Screening and testing, (2007)
[10]
NHS breast screening programme, (2008)